Articles by Xavier Anglaret

1 2 3 4 5

Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d’Ivoire

Kroidl, Arne; Ello, Frederic; Mgaya, Jimson; More

AIDS. 31(4):501-509, February 20th, 2017.

Early antiretroviral therapy initiation in west Africa has no adverse social consequences: a 24-month prospective study

Jean, Kévin; Niangoran, Serge; Danel, Christine; More

AIDS. 30(10):1677-1682, June 19th, 2016.

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

Kouamé, Gérard; Danel, Christine; Moh, Raoul; More

AIDS. 28(10):1533-1535, June 19th, 2014.

Genotypic resistance profiles of HIV-2-treated patients in West Africa

Charpentier, Charlotte; Eholié, Serge; Anglaret, Xavier; More

AIDS. 28(8):1161-1169, May 15th, 2014.

Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age

Ouattara, Eric N.; Anglaret, Xavier; Wong, Angela Y.; More

AIDS. 26(5):625-634, March 13th, 2012.

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters

Minga, Albert K; Lewden, Charlotte; Gabillard, Delphine; More

AIDS. 25(6):819-823, March 27th, 2011.

Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinants

Toure, Siaka; Kouadio, Bertin; Seyler, Catherine; More

AIDS. 22(7):873-882, April 23rd, 2008.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

Moh, Raoul; Danel, Christine; Messou, Eugène; More

AIDS. 21(18):2483-2491, November 30th, 2007.

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

Seyler, Catherine; Adjé-Touré, Christiane; Messou, Eugène; More

AIDS. 21(9):1157-1164, May 31st, 2007.

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

Walensky, Rochelle P; Weinstein, Milton C; Yazdanpanah, Yazdan; More

AIDS. 21(8):973-982, May 11th, 2007.

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis

Yazdanpanah, Yazdan; Losina, Elena; Anglaret, Xavier; More

AIDS. 19(12):1299-1308, August 12th, 2005.

Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire

Anglaret, Xavier; Messou, Eugène; Ouassa, Timothée; More

AIDS. 17(4):575-584, March 7th, 2003.

Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Côte d'Ivoire

Anglaret, Xavier; Dakoury-Dogbo, Nicole; Bonard, Dominique; More

AIDS. 16(6):909-918, April 12th, 2002.

Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire

Castetbon, Katia; Anglaret, Xavier; Attia, Alain; More

AIDS. 15(7):869-876, May 4th, 2001.

1 2 3 4 5